News

This Device Could Spot Diabetes Before It Starts, No Needles Required
Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...
BioWorld22h
Abbott studies show CGM users have fewer hospitalizations
A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces ...
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...
Drug Delivery Business1d
Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.
Drug Delivery Business3d
Glucotrack can proceed with long-term glucose monitor study in Australia
Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...
Onlymyhealth14h
Type 1 Diabetes Diagnosed In Adulthood Tied To Higher Heart Disease And Death Risk: Study Finds
Adults diagnosed with type 1 diabetes face significantly higher risks of heart disease and early death a new study finds—highlighting the urgent need for better care and treatment ...
Oura brings prescription-free blood glucose monitoring and more to the Oura app
Both Meal and Glucose are now available to Oura members on iOS and Android in the US. The company says international ...